Risperdal Lawsuit Settlement |
The United States District Court for the Eastern District of Pennsylvania has approved a $158 million settlement in a lawsuit filed by parents and patients who claim that Johnson & Johnson’s Risperdal and Janssen Pharmaceuticals’ Invega caused them to develop tardive dyskinesia, also known as TD. The “risperdal lawsuit update 2021” is a settlement that … Read more